Market Overview

Deutsche Bank Reiterates Buy Rating, $88 PT on Mead Johnson Nutrition

Related MJN
Benzinga's M&A Chatter for Wednesday June 18, 2014
Is Mead Johnson Preparing To Be Acquired?

In a report published Wednesday, Deutsche Bank reiterated its Buy rating and $88.00 price target on Mead Johnson Nutrition (NYSE: MJN).

Deutsche Bank noted, “Although the stock has been under pressure given concerns around China growth, we continue to view the LT outlook as compelling. Mead enjoys a modest premium valuation vs. global CPG peers. But we see this as justified given leading global share in a rational category, excellent margins, and investments that should yield high returns.”

Mead Johnson Nutrition closed on Tuesday at $73.59.

Posted-In: Deutsche BankAnalyst Color Reiteration Analyst Ratings

 

Most Popular

Related Articles (MJN)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free